Search
News
Press releases
Contact
Work with us
About us
Idea and vision
Management Team
Board of Directors
Scientific Advisory Board
Technology
Abiprot® Antibody Discovery Platform
Scientific publications
Portfolio
Pipeline
Programs
Corporate Governance
ANNUAL GENERAL MEETING 2023
Rights issue 2023
Previous General Meetings
Board of Directors and Management
Nomination Committee
Articles of Association
Investor Relations
Financial Reports
Annual Reports for the years 2016–2022
Convertible bonds rights issue 2022
Investor Relations contact
Partnering
Partnership & Collaboration
Oblique
News
Notice convening the Extraordinary
Notice convening the Extraordinary General Meeting on December 6 at 2pm
Oblique Therapeutics AB – Kallelse till extra bolagsstämma 6 december 2019
